-
Taking Aim at AML: The Mission Continues
Protein profiling may identify moving treatments targets for acute myeloid leukemia. Find out how researchers team up in the VENAML clinical trial to reduce cancer development.
-
Life after St. Jude: Dakota’s Dreams
This young survivor's treatment was made possible in part by the Pediatric Cancer Genome Project.
-
Life After Treatment: My Legacy
A long-term cancer survivor shares his story of St. Jude, how cancer shaped his life, and what his life is like after remission.
-
Tailored Therapy: Saving Bel's Life
A St. Jude study personalizes treatment for patients who inherit a high-risk gene variation.
-
A Seat at the Table: Youth Help HIV/AIDS Researchers
One group of St. Jude patients helps HIV/AIDS researchers plan clinical trials and other important projects.
-
Soft Landings with the Transition Oncology Program
The new Transition Oncology Program (TOP) provides support and education to families whose children are returning home after cancer therapy.
-
Half-Matched Transplants, Whole Hope for Cures
A new study for half-matched transplants aims to cure high-risk blood cancers. The HAP2HCT clinical trial aims to kill remaining cancer cells, reduce the risk of GVHD and help patients’ immune systems recover quickly.
-
It's a BRAVE New World for Mobility
The new BRAVE (Beginning Restorative Activities Very Early) program seeks to help mobilized patients as soon as possible to decrease their time in the pediatric intensive care unit and reduce delirium and ventilation time.
-
St. Jude LIFE Celebrates Milestone
St. Jude welcomes its 5,000th patient back to campus in an extraordinary study designed to help the survivors of today and the children of tomorrow.
-
Hodgkin Lymphoma: In Search of the Sweet Spot
A new study aims to reduce long-term effects of Hodgkin lymphoma treatment.